Montelukast Prescribing at MIDDLEWOOD PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,705
Total Quantity
61.0K
NHS Cost
£3.6K
vs National Avg
+149%
MIDDLEWOOD PARTNERSHIP prescribed 1,705 items of Montelukast over the last 12 months at a cost of £3,575 to the NHS. This is 149% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
150
Jul 2026
137
Jul 2026
155
Jul 2026
142
Jul 2026
133
Jul 2026
161
Jul 2026
136
Jul 2026
162
Jul 2026
149
Jul 2026
125
Jul 2026
130
Jul 2026
125
Prescribing Details
| Total Items | 1,705 |
|---|---|
| Total Quantity | 60,998 |
| Total NHS Cost | £3,575 |
| Presentations | 4 different forms |
| vs National Average | +149% |
Montelukast Prescribing Comparison
| This practice | 1,705 items |
|---|---|
| National average per practice | 685 items |
| Difference | +149% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.